Quarterly Results

FCS SOFTWARE SOLUTIONS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/10/2019 ,inter alia, to consider and approve following businesses: 1. To fix date, time and venue for the 26th Annual General Meeting and to approve the draft notice thereof 2. To consider businesses to be transacted at Annual General Meeting Ordinary business: To receive, consider and adopt the Audited Financial Statements for the year ended as on 31st March, 2019 together with the reports of the Directors and Auditors thereon To consider re-appointment of Sunil Sharma, Director liable to retire by rotation Special Business: To consider re-appointment of Ms. Shweta Shatsri, Independent director. To consider re-appointment Mr. Shayam Sunder Sharma, Independent director. To consider re-appointment of Mr Dalip Kumar, Chairman & Managing Director 3. To consider and take note on the draft Directors Report and financial year ended as on 31st March 2019 4. To fix the voting period and cut-off date 5. To determine dates of book closure 6. To take note the Secretarial Audit Report for the financial year 2018-19

GTPL Hathway Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/10/2019 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2019.

Indiabulls Housing Finance Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/10/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that a meeting of the Board of Directors of the Company will be held on Monday, October 14, 2019, to consider, inter alia, the proposal of Buy-back of equity shares of the Company. We further wish to inform that in terms of SEBI (Prohibition of Insider Trading) Regulations, and Code of Conduct for Prevention of Insider Trading of the Company, the Trading Window for dealing in securities of the Company which had been closed earlier, shall remain closed till 48 hours after the declaration of financial results for the quarter ended September 30, 2019.

PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/10/2019 ,inter alia, to consider and approve 1. To consider, approve and take on record the unaudited Standalone and Consolidated Financial Results for the quarter ended 30th September, 2019. 2. To consider and approve the resignation of Mr. Gursimran Singh, Director of the Company and Ms. Simmi Chhabra, Independent Director of the Company. 3. To consider and approve the appointment of new Directors on the Board. 4. Any other matter with the permission of Chair.